BRCA2 and breast carcinoma: The communication of the genetic test result, i.e., a pathogenic variant on a high breast cancer susceptibility gene such BRCA1 or BRCA2, a negative or an uninformative test result, or a VUS (samples 1 and 2) had no significant influence on distress measured after the post-test consultation: HADS predicted means (95% CI) ranged from 8.8 (6.9–10.8) (negative result) to 10.8 (10.0–12.0) (uninformative result) at T1 and from 8.3 (7.2–9.4) (pathogenic variant) to 10.0 (8.4–10.9) (uninformative result) at T2 (Supplementary Tables S7 and S8).